Published in Vopr Virusol on December 21, 1998
Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology (2000) 2.21
Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections. J Infect Dis (1999) 1.83
Characterization of the L gene and 5' trailer region of Ebola virus. J Gen Virol (1999) 1.63
Inactivation of Ebola virus with a surfactant nanoemulsion. Acta Trop (2003) 1.02
[Analysis of the mechanism of cell depolarization at initial stages of virus-cell interaction]. Dokl Akad Nauk (1998) 0.94
[Experimental Ebola fever in Macaca mulatta]. Vopr Virusol (1995) 0.93
Elaboration of laboratory strains of Ebola virus and study of pathophysiological reactions of animals inoculated with these strains. Acta Trop (2003) 0.93
Immune and pathophysiological processes in baboons experimentally infected with Ebola virus adapted to guinea pigs. Immunol Lett (2000) 0.88
[The effect of some physical and chemical factors on inactivation of the Ebola virus]. Vopr Virusol (1995) 0.85
[Experimental study of Ebola hemorrhagic fever in baboon models]. Biull Eksp Biol Med (1995) 0.81
A prototype prophylactic anti-influenza preparation in aerosol form on the basis of Abies sibirica polyprenols. J Aerosol Med (2005) 0.79
Effect of intramuscularly injected polyprenols on influenza virus infection in mice. Antivir Chem Chemother (2000) 0.78
A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus. Arch Virol (2014) 0.78
[The properties of Ebola virus proteins]. Vopr Virusol (2007) 0.78
[Hematological and immunological parameters during Ebola virus passages in guinea-pigs]. Vopr Virusol (2006) 0.77
[Relationship between the level of specific antibodies with disease outcome in Cercopithecus aethiops monkeys in experimental Marburg disease]. Vopr Virusol (1997) 0.77
[Functional activity of peritoneal macrophages in experimental Ebola fever]. Vestn Ross Akad Med Nauk (2004) 0.77
Symptoms of infection caused by SARS coronavirus in laboratory mice and guinea pigs. Dokl Biol Sci (2004) 0.77
[Assay for level of Marburg virus in blood and isolates from experimentally infected animals]. Vopr Virusol (2000) 0.77
[Dynamics of complement hemolytic activity in experimental Ebola infection]. Vopr Virusol (2004) 0.77
[Hemostatic properties of gaseous ozone]. Biull Eksp Biol Med (1995) 0.77
[Immunobiological properties of vp24 protein of Ebola virus expressed by recombinant vaccinia virus]. Vopr Virusol (1997) 0.76
[Human recombinant antibodies to Ebola virus: preparation and characteristics]. Vopr Virusol (2005) 0.76
[Comparative analysis of the susceptibility and productivity of respiratory tract target cells of mice and rats exposed to inflienza virus in vitro]. Vestn Ross Akad Med Nauk (2008) 0.75
[A study of possibility to predict the sensitivity of different respiratory tract divisions to influenza]. Vestn Ross Akad Med Nauk (2007) 0.75
[The detection of the Marburg virus antigen by solid-phase immunoenzyme analysis]. Vopr Virusol (1992) 0.75
[A new setup for the generation and studies of mono-disperse microbiological aerosols in medical-and-biological research]. Vestn Ross Akad Med Nauk (2004) 0.75
[Results of the participation of 360 laboratories of Russia in the external quality assessment program for HBsAG tests]. Klin Lab Diagn (2007) 0.75
[Development and application of an immunoenzyme test system for diagnosing Ebola fever]. Vopr Virusol (1995) 0.75
[Mechanisms of action of aerosol preparations based on Abies siberica polyprenols in experimental influenza infection]. Vopr Virusol (2002) 0.75
Variability of the content of live microorganisms in the atmospheric aerosol in southern regions of western Siberia. Dokl Biol Sci (2003) 0.75
[Pulmonary cell susceptibility in mice and rats to influenza virus when infected in vivo and in vitro]. Vestn Ross Akad Med Nauk (2004) 0.75
[Reactogenicity, safety and immunogenicity of a recombinant bivaccine against smallpox and hepatitis B in limited clinical trials]. Vopr Virusol (2004) 0.75
[Analysis of antigenic determinant profiles of the Ebola virus VP35 protein N-terminal region using its short recombinant fragments]. Mol Gen Mikrobiol Virusol (2003) 0.75
[Recombinant full-size human antibody to Ebola virus]. Bioorg Khim (2008) 0.75
[A comparison of the methods of fluorescent antibodies and solid-phase immunoenzyme analysis in the detection of Marburg virus antibodies]. Vopr Virusol (1992) 0.75
[Characteristics of the kidney functional state after a single dose of thyroxine in white rats]. Patol Fiziol Eksp Ter (2005) 0.75
[The influence of glucocorticoid immunosuppression on the course of experimental influenza pneumonia]. Vestn Ross Akad Med Nauk (2006) 0.75
[Effect of ultraviolet irradiation of human blood on serum concentration of triiodothyronine and thyroxine]. Fiziol Zh (2003) 0.75
[Changes in certain indicators of hemostasis in rabbits upon administration of Ebola virus preparations]. Vopr Virusol (1997) 0.75
[Preparation of rabbit antiserum to Ebola virus]. Vopr Virusol (1995) 0.75
[Comigration of root nodule bacteria and bean plants to new habitats: coevolution mechanisms and practical importance (review)]. Prikl Biokhim Mikrobiol (2013) 0.75
[Strain differences related to Ebola virus reproduction in peritoneal macrophages and in aorta explants of guinea pigs]. Vopr Virusol (2004) 0.75
[THERMAL STABILITY AS A PROGNOSTIC INDICATOR OF CONSERVATION OF LIVE EMBRYONIC SMALLPOX VACCINE (TEOVAC) DURING STORAGE]. Zh Mikrobiol Epidemiol Immunobiol (2016) 0.75
[The simple method of direct estimation of infectious process in mice and rats aerogenically infected with influenza virus]. Vopr Virusol (2002) 0.75
[Effect of Ebola virus antigen on proliferative response of human lymphocytes in vitro: imbalance in production of tumor necrosis factor alpha and interleukin-1]. Vopr Virusol (2003) 0.75
[The avidicity index of specific IgG in the diagnosis of diseases caused by west Nile and tickborne encephalitis viruses]. Klin Lab Diagn (2007) 0.75
[Effect of inactivated Ebola virus on colony forming activity of human hematopoietic stem cells]. Vopr Virusol (1997) 0.75
[In vitro synthesis of immunoglobulins caused by an inactivated Ebola virus]. Vopr Virusol (2003) 0.75
[Evaluation of Ebola virus reproduction in adult ICR white mice]. Vopr Virusol (2010) 0.75
[Effects of repeated administration of Ebola virus preparations on dynamics of immunologic parameters]. Biull Eksp Biol Med (1999) 0.75
[The Principle of Genome Complementarity in the Enhancement of Plant Adaptive Capacities]. Genetika (2015) 0.75
[Prophylactic efficacy of aerosol preparations based on Abies siberica polyprenols in experimental influenza infection]. Vopr Virusol (2002) 0.75
[Methods for controlling colonization of air and laboratory surfaces by pathogens of certain especially dangerous viral infections]. Vopr Virusol (1997) 0.75
Study of the pathogenesis of Ebola fever in laboratory animals with different sensitivity to this virus. Bull Exp Biol Med (2001) 0.75
[Antigenic differences in wild-type and guinea pig-adapted Ebola virus strains]. Vopr Virusol (2011) 0.75
[Isolation and characteristics of regional cytomegalovirus strains]. Vopr Virusol (1997) 0.75
[Effect of exogenous thyroxin on renal ion-regulating and acid-secreting functions in white rats]. Aviakosm Ekolog Med (2008) 0.75
[Sensitivity of white mice to influenza virus (A/Aichi/2/68) in aerogenic infection]. Vopr Virusol (1999) 0.75
Amplitude-frequency polarization of biological particles induced by external factors. Dokl Biochem Biophys (2001) 0.75
[Molecular mechanisms of Ebola virus reproduction]. Vopr Virusol (2007) 0.75
[Target-cell susceptibility and lung phagocyte activity in mice with influenza virus resistance lowered by glucocorticoidal immunosuppression]. Vestn Ross Akad Med Nauk (2007) 0.75
[Regulatory genes of garden pea (Pisum sativum L.) controlling the development of nitrogen-fixing nodules and arbuscular mycorrhiza: a review of basic and applied aspects]. Prikl Biokhim Mikrobiol (2007) 0.75
[Development of a method for rapid detection of Ebola virus antibodies and antigen]. Vopr Virusol (2007) 0.75
[Ways to improve training of the populace for rendering medical first aid to casualties in extreme situations]. Voen Med Zh (2003) 0.75
[Study of the phagocytic ability of blood polymorphonuclear leukocytes from rabbits and guinea pigs upon administering Ebola virus]. Vopr Virusol (1997) 0.75
[Antigenic structure of Ebola virus VP35 protein]. Vopr Virusol (2001) 0.75
[Titration of Ebola and Marburg viruses by plaque formation under semi liquid agar]. Vopr Virusol (2003) 0.75
[Validation of the modified algorithm for predicting host susceptibility to viruses taking into account susceptibility parameters of primary target cell cultures and natural immunity factors]. Vestn Ross Akad Med Nauk (2010) 0.75
[Study of the functional role of mutation in the guinea pig-adapted Ebola virus genome on a Drosophila melanogaster model]. Vopr Virusol (2011) 0.75
[Antiviral activity of oral ultralow doses of antibodies to gamma-interferon: experimental study of influenza infection in mice]. Antibiot Khimioter (2004) 0.75
The growth of human HIV-1 infected U937 cells in immune-deprived mice. Biomed Pharmacother (1995) 0.75
[Cloning and primary structure determination of genes coding for IE2 and PP150 proteins of human cytomegalovirus]. Mol Gen Mikrobiol Virusol (1996) 0.75
[Monoclonal antibodies to Ebola virus: isolation, characteristics, and study of cross reactivity with Marburg virus]. Vopr Virusol (2000) 0.75
[Change in biochemical and hemostatic indicators in guinea pigs upon administering Ebola virus preparations]. Vopr Virusol (1997) 0.75
[Quantitative assessment of in vitro neutralizing activity of secretory factors from rat lungs against influenza virus]. Vestn Ross Akad Med Nauk (2009) 0.75
Recombinant monoclonal human antibodies against Ebola virus. Dokl Biochem Biophys (2001) 0.75
[Mechanisms of mice resistance to influenza virus A/AICHI/2/68 after preventive injection with polyprenols ]. Vopr Virusol (2001) 0.75
[Effect of an infections dose of the Ebola virus on survivability and immunologic indicators in guinea pigs]. Vopr Virusol (1999) 0.75
[Requirements of the urban population for therapeutic care at home]. Sov Zdravookhr (1965) 0.75
[Molecular genetic mechanisms used by legumes to control early stages of mutually beneficial (mutualistic) symbiosis]. Genetika (2009) 0.75